The optimal duration of treatment with alendronate tablets has not been determined, and regular dosing evaluations are needed depending on the condition and physical status. Discontinuation of alendronate tablets should generally be considered after 3 to 5 years of use in patients at low risk of fracture.
Alendronate Sodium Tablets are usually used for the treatment of osteoporosis in postmenopausal women, which is beneficial for the prevention of hip and spine fractures, and can also be used for the treatment of osteoporosis in men in order to increase bone mass. The duration of the medication is related to the patient’s condition and physical fitness, and there is usually no fixed period of time.
Alendronate sodium tablets may cause bloating, constipation, nausea and other adverse reactions after use, resulting in delayed esophageal emptying esophageal abnormalities, standing or sitting straight for less than 30 minutes, allergic to the components of the product, hypocalcemia and other patients are prohibited.
Patients are advised to use the drug strictly under the supervision of a physician.